Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/25 19:55 | 5/1/25 | RNA | Health | Drug | Pharmaceutical Preparations | Gallagher Kathleen P. | CA | O | Chief Pr | 8 | M.d | 1,085 | 23.08 | 0 | 47 | 999% | 51 | D | ||||||||||||||
5/2/25 19:55 | 5/1/25 | RNA | Health | Drug | Pharmaceutical Preparations | Gallagher Kathleen P. | CA | O | Chief Pr | 8 | S.d | -1,085 | 23.08 | 0 | -47 | 51 | D | |||||||||||||||
3/21/25 18:44 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | Hughes Steven George | CA | O | Chief Me | 1 | S | -297 | 31.06 | 0 | -10 | 73 | D | |||||||||||||||
3/21/25 18:42 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | 1 | S | -980 | 31.06 | 0 | -32 | 306 | D | |||||||||||||||
3/21/25 18:40 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | Flanagan W. Michael | CA | O | Chief Sc | 3 | S.d | -1,253 | 24.20 | 0 | -52 | 92 | D | |||||||||||||||
3/21/25 18:38 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | Maclean Michael F | CA | O | CFO | 1 | S | -246 | 31.06 | 0 | -8 | 97 | D | |||||||||||||||
3/21/25 18:36 | 3/20/25 | RNA | Health | Drug | Pharmaceutical Preparations | McCarthy Teresa | CA | O | CHRO | 1 | S | -242 | 31.06 | 0 | -8 | 97 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |